Biography

Dr. Jernigan received her Ph.D. from the University of New Mexico School of Medicine and did her post-doctoral training at the Center for Cardiovascular-Renal Research at the University of Mississippi Medical Center in Jackson, Mississippi.

Areas of Specialty

vascular physiology, calcium handling, ion channel physiology, metabolic-mitochondrial dysfunction, pulmonary hypertension, oxidative stress

Gender

Female

Languages

  • English

Research

Dr. Jernigan’s research program focuses on a unique class of voltage-insensitive, non-selective cation channels called acid-sensing ion channels (ASIC). Her laboratory identified a unique role for ASIC1 to contribute to the development of hypoxia pulmonary hypertension, which is a progressive and often fatal outcome of chronic lung diseases (4th leading cause of death in the US). More specifically, her lab examines the contribution of ASIC1 to the metabolic-mitochondrial dysfunction in pulmonary hypertension. In addition, her work is at the forefront of determining the involvement of ASIC1 in the systemic hypertensive circulation and its association with aging and diabetes. The outcomes of this research will enable a fundamental understanding of ASIC1 in cardiovascular disease which will permit further evaluation of the therapeutic potential of ASIC1.

Research and Scholarship

Dr. Jernigan’s research program focuses on a unique class of voltage-insensitive, non-selective cation channels called acid-sensing ion channels (ASIC). Her laboratory identified a unique role for ASIC1 to contribute to the development of hypoxia pulmonary hypertension, which is a progressive and often fatal outcome of chronic lung diseases (4th leading cause of death in the US). More specifically, her lab examines the contribution of ASIC1 to the metabolic-mitochondrial dysfunction in pulmonary hypertension. In addition, her work is at the forefront of determining the involvement of ASIC1 in the systemic hypertensive circulation and its association with aging and diabetes. The outcomes of this research will enable a fundamental understanding of ASIC1 in cardiovascular disease which will permit further evaluation of the therapeutic potential of ASIC1. Publications: https://www.ncbi.nlm.nih.gov/myncbi/nikki.jernigan.1/bibliography/public/